Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Site

Explore clinical trials studying Neoplasms by Site. Study availability and eligibility vary by location and protocol.

50,540 public trials 10,738 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Site trial results

Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

NCT07173751

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University Of California - San Diego Moores Cancer Center La Jolla, California, United States
  • Cedar Sinai - Samuel Oschin Cancer Center Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
View all 181 locations
View Trial Details
Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT04267848

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 1151 locations
View Trial Details
Recruiting

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

NCT07361497

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Local Institution - 0780 Chandler, Arizona, United States
  • Intermountain Health Cancer Center Lutheran Hospital Golden, Colorado, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
View all 259 locations
View Trial Details
Recruiting

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

NCT06902376

Conditions
Anaplastic Thyroid Cancer, BRAF Mutation-Related Tumors, Carcinoma, +11 more
Locations
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions